FDA Approved: DESLORATADINE — Supplemental Application (Bionpharma Inc.)

View source ↗

Summary

FDA approves a supplemental application for Desloratadine from Bionpharma Inc., confirming the approval of the generic product under ANDA 078357.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Idiopathic Urticaria

Drugs mentioned

• Desloratadine (desloratadine)

Snippet

SUPPL AP for DESLORATADINE (DESLORATADINE)